abstract |
This invention relates to biomarkers for aminopeptidase inhibition. These biomarkers may be useful, for example, in assessing the extent of aminopeptidase inhibition in vivo or in monitoring cancer treatments using aminopeptidase inhibitors, such as bestatin or CHR-2797. |